Gilead sued over pricing of hepatitis C drug
December 10, 2014 at 15:37 PM EST
Philadelphia's transit agency has filed a lawsuit against Gilead Sciences challenging the "exorbitant pricing" of its hepatitis C drug Sovaldi.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.